Safety, Tolerability, and Pharmacokinetics of KarXT and Dual-burst Release of Xanomeline With Immediate-release Trospium Chloride in Adolescents With Psychiatric Disorders
Clinical trial NCT06853171 · COMPLETED
Trial details
- NCT number
- NCT06853171
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-29
- Primary completion
- 2025-07-22
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.